Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-14 Purchase |
2023-06-15 8:13 pm |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
30,000 | $0.2149 | $6,447 | 563,223 (Indirect Direct) |
View |
2022-12-22 Purchase |
2022-12-27 6:47 pm |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
25,000 | $0.285 | $7,125 | 533,223 (Indirect Direct) |
View |
2022-08-15 Purchase |
2022-08-17 8:20 pm |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
10,000 | $0.97 | $9,700 | 553,223 (Indirect Direct) |
View |
2020-12-23 Sale |
2020-12-28 9:46 pm |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
900 | $2.55 | $2,295 | 543,494 (Indirect Direct) |
View |
2020-12-21 Sale |
2020-12-23 9:12 pm |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
42,800 | $0.30551 | $13,076 | 556,147 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-07-01 Option Award |
2023-07-03 5:46 pm |
N/A 2033-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Chairman |
50,000 | $0 | 50,000 (Direct) |
View |
2023-06-23 Option Award |
2023-06-27 9:30 pm |
N/A 2033-06-23 |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
110,000 | $0 | 673,223 (Direct) |
View |
2022-12-01 Ownership |
2023-02-14 4:16 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
25,000 | $0 | 6,849,242 (Direct) |
View |
Ownership |
2023-02-14 4:16 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
0 | $0 | 6,849,242 (Indirect) |
View |
2022-08-15 Option Award |
2022-08-17 8:20 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
55,000 | $0 | 553,223 (Direct) |
View |
2022-06-24 Exercise |
2022-07-19 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
10,000 | $0 | 394,111 (Direct) |
View |
2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
50,000 | $0 | 50,000 (Direct) |
View |
2021-12-01 Ownership |
2022-02-11 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
14,700 | $0 | 6,874,242 (Direct) |
View |
Ownership |
2022-02-11 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
0 | $0 | 6,874,242 (Indirect) |
View |
2021-07-01 Option Award |
2021-07-01 6:21 pm |
N/A 2031-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
80,000 | $0 | 80,000 (Direct) |
View |
2021-06-24 Option Award |
2021-06-28 8:32 pm |
N/A 2031-06-23 |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
55,000 | $0 | 55,000 (Direct) |
View |
2021-06-22 Exercise |
2021-06-23 1:15 pm |
N/A 2021-06-30 |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
61,800 | $0 | 6,888,942 (Direct) |
View |
2021-06-22 Exercise |
2021-06-23 1:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
61,800 | $2.2 | 6,888,942 (Direct) |
View |
2020-12-01 Ownership |
2021-02-12 5:00 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
17,500 | $0 | 6,827,142 (Direct) |
View |
Ownership |
2021-02-12 5:00 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
0 | $0 | 6,827,142 (Indirect) |
View |
2020-12-23 Exercise |
2020-12-28 9:46 pm |
N/A 2020-12-28 |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
66,508 | $1.34 | 543,494 (Direct) |
View |
2020-12-21 Exercise |
2020-12-23 9:12 pm |
N/A 2020-12-28 |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
58,492 | $1.34 | 556,147 (Direct) |
View |
2020-12-11 Option Award |
2020-12-15 06:15 am |
N/A N/A |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
5,909 | $0 | 396,923 (Direct) |
View |
2020-07-01 Option Award |
2020-07-02 5:00 pm |
N/A 2030-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
70,000 | $0 | 70,000 (Direct) |
View |
2020-06-17 Option Award |
2020-06-19 5:34 pm |
N/A N/A |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
57,000 | $0 | 57,000 (Direct) |
View |